Intelligence Β· Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS β€” grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≀24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months β€” use filters for patent-cliff planning.

Page 12 of 13

  1. US 7470790

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7452679

    Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7381748

    Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase

    Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7371719

    Self-assembly of peptide-amphiphile nanofibers under physiological conditions

    Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7335382

    Compositions and methods for the treatment and prevention of cancer

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7329775

    Compounds and related methods for mutant p53 reactivation

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7279326

    Composition for delivery of a mitochondrial genome to a cell

    Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7270960

    Diagnosis of ovarian carcinomas

    Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7271186

    Nanomolar Ξ²-lactamase inhibitors

    Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7208171

    Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7160868

    Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7144867

    Anticancer glycoside compounds

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7118747

    AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

    Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7105496

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7087715

    Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses

    Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 6936448

    Nucleic acids and proteins of a rat ganglioside GM1-specific Ξ±1-2fucosyltransferase and uses thereof

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  17. US 6919309

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  18. US 6889145

    Three-dimensional model of a Fc region of an IgE antibody and uses thereof

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  19. US 6887845

    Polypeptoid pulmonary surfactants

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  20. US 6863887

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  21. US 6803486

    Selective neuronal nitric oxide synthase inhibitors

    Expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  22. US 6797691

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  23. US 6794413

    Compounds and related methods for inhibition of &ggr;-aminobutyric acid aminotransferase

    Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  24. US 6780984

    Method for prognosing cancer and the proteins involved

    Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  25. US 6734172

    Surface receptor antigen vaccines

    Expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  26. US 6699481

    Peptides for inhibition of herpes simplex virus entry

    Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  27. US 6677306

    Chondrogenic and osteogenic inducing molecule

    Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  28. US 6670333

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  29. US 6656714

    Nucleic acids and proteins of a rat ganglioside GM1-specific &agr;1→2 fucosyltransferase and uses thereof

    Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  30. US 6641818

    Cellular proteins which mediate herpesvirus entry

    Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  31. US 6579857

    Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

    Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  32. US 6576609

    Methods and compositions for generating angiostatin

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  33. US 6573058

    Antibody to herpes virus entry receptor protein

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  34. US 6559128

    Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof

    Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  35. US 6525096

    GABA and L-glutamic acid analogs for antiseizure treatment

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  36. US 6468537

    Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus

    Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  37. US 6448238

    Inhibitors of &bgr;-lactamases and uses therefor

    Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  38. US 6444431

    Angiostatin receptor

    Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  39. US 6417174

    Inhibitors of &bgr;-lactamases and uses therefor

    Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  40. US 6414024

    GABA and L-glutamic acid analogs for antiseizure treatment

    Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  41. US 6391850

    Methods and compositions for inhibiting angiogenesis

    Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  42. US 6372713

    Anti-depressant effects of corticotropin release inhibiting factor

    Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  43. US 6359169

    GABA and L-glutamic acid analogs for antiseizure treatment

    Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  44. US 6348571

    Corticotropin release inhibiting factor and methods of using same

    Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  45. US 6342529

    GABA and L-glutamic acid analogs for antiseizure treatment

    Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  46. US 6329170

    Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1.fwdarw.2fucosyltransferase and uses thereof

    Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  47. US 6303336

    Herpes virus entry receptor protein

    Expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  48. US 6291526

    GABA and L-glutamic acid analogs for antiseizure treatment

    Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory